Previous DRSG Seminars – 2000-2012
Improving Risk Assessment for Mixtures Using Dose-Dependent Responses
Resha Putzrath, Navy and Marine Corps Public Health Center
4 September 2012
Evaluating the Plausibility of Estrogen Receptors as Mediators of BPA Toxicity in the Context of Human Serum Concentrations of Unconjugated BPA
Justin Teeguarden, Pacific Northwest National Laboratory
4 June 2012
Bisphenol A: Evaluating Toxicity and Dose Response in Rodent Models
Barry Delclos, U.S. FDA
3 April 2012
Computational Toxicology and High-Throughput Risk Assessment
Richard Judson, U.S. EPA
6 September 2011
Integration of Dosimetry, Human Exposure and High-Throughput Screening Data in the Toxicity Assessment of Environmental Chemicals
Barbara Wetmore, Hamner Institutes for Health Sciences
June 7, 2011
NexGen Risk Assessments: Challenges and Opportunities for Dose-Response Assessment
Weihsueh Chiu, U.S. EPA
12 April 2011
The Use and Misuse of Dose Thresholds in Risk Assessment
Kenny Crump, Louisiana Tech University
7 September 2010
Microbial Dose-Response & Its Use in Estimating the Benefits of EPA’s Drinking Water Rules
Jeff Swartout, U.S. EPA National Center for Environmental Assessment
Mike Messner, U.S. EPA Office of Ground Water and Drinking Water
Stig Regli, U.S. EPA Office of Ground Water and Drinking Water
3 August 2010
Threshold of Toxicological Concern (TTC)
Michael Laufersweiler, Procter & Gamble Central Product Safety, and
Stephen Olin, ILSI Research Foundation
3 March 2010
High Throughput Screening for Hazard and Risk of Environmental Contaminants
David J. Dix, U.S. EPA
6 October 2009
Using Empirical Data on Toxicity Pathways in the Prediction of Responses at Low Doses
Paul Price, Dow Chemical Company
1 September 2009
Chemical-Specific Adjustment Factors: The IPCS Approach to Developing Non-Default Values for Inter and Intra-species Extrapolation
John Lipscomb, U.S. EPA
Categorical Regression Modeling of Multiple Effects from Chemical Mixture Exposures in Cumulative Risk Assessment
Linda Teuschler, U.S. EPA
9 June 2009
Discussion of National Academy of Sciences Report - Science and Decisions: Advancing Risk Assessment
Michael Dourson, TERA
3 March 2009
The BMD Approach in Europe: Recent Developments in Acceptance, and Some Specific Views
Wout Slob, RIVM
2 September 2008
Dose-Response Analysis in Environmental Risk Assessment:
Where Are We, and Where Are We Going?
Weihsueh Chiu, U.S. EPA
3 June 2008
Characterizing Dose-Response Model Uncertainty Using Model Averaging
Matthew Wheeler, NIOSH
5 March 2008
Radiation Cancer Risk Estimates and the Use of the Linear Nonthreshold Model
Julian Preston, U.S. EPA
11 September 2007
Toxicokinetics and Risk Assessment, a text
John Lipscomb, U.S. EPA
5 June 2007
PBPK Modeling for Acrylamide: Relating Mechanisms, Adducts, Metabolites, and Kinetics to Risk Assessment
Daniel R. Doerge; John F. Young, NCTR, U.S. FDA
6 March 2007
Intraspecies Variability in Toxicant Effects: Nuisance, Nemesis or Sustenance for Risk Assessment?
Robert MacPhail, U.S. EPA
5 September 2006
Mode of Action in Assessing the Human Relevance of Animal Tumors: An EPA Perspective
Vicki Dellarco; Anna Lowit, U.S. EPA
6 February 2006
Inhalation Toxicity of Single Wall Carbon Nanotubes
Robert R. Mercer, NIOSH Unique Properties of Nanomaterials that Raise Concerns for Toxicology Research
Jo Anne Shatkin, The Cadmus Group
6 June 2006
Computational Systems Biology and Dose Response Assessment
Mel Andersen, CIIT Centers for Health Research
6 September 2005
Age-Related Differences in Susceptibility to Carcinogenesis—Human Risk Inferences from an Analysis of Animal Bioassay Data
Dale Hattis, Clark University
7 June 2005
Update on International Initiatives for Chemical Specific Adjustment Factors and Physiologically Based Pharmacokinetic (PBPK) Models for Use in Risk Assessment
Bette Meek, Health Canada
1 March 2005
Benchmark-Dose Shopping with Proper Confidence
Walter Piegorsch, University of South Carolina
7 September 2004
Dose-Dependent Transitions in Toxic Mechanisms: Implications for Risk Assessment
David Gaylor, Gaylor and Associates
1 June 2004
Arsenic: Proposed Mechanisms and Risk Assessment Implications
Michael Luster, NIOSH
2 March 2004
Cumulative Risk Assessment for Chemical Mixtures
James Chen, U.S. National Center for Toxicological Research
2 September 2003
Dose-Response Curves in Chemical Carcinogenesis
William Waddell, University of Louisville
3 June 2003
Bystanders, Adaptive Responses and Genomic Instability – Potential Modifiers of Low-Dose Cancer Responses
Julian Preston, U.S. EPA
4 March 2003
Model Uncertainty in Microbial Risk Assessment
Ravi Varadhan, Johns Hopkins University
3 September 2002
Computational Modeling of Mechanisms of Nonmonotonic Dose-Response: Androgen Receptor Activation and Tumor Incidence
Rory Conolly, CIIT Centers for Health Research
4 June 2002
Variability in Dose-Response Assessments
Wout Slob, RIVM
5 March 2002
Dioxin: Dose-Response for Acute Effects
Jim Wilson, Resources for the Future
4 September 2001
Assessment of Risks to Children from Exposure to Environmental Agents
Gary Kimmel, U.S. EPA
Chemical Mixtures Risk Assessment: Current Approaches and Emerging Issues
Peter Robinson, ManTech
Integrating Toxicokinetics and Toxicodynamics in Mechanistic Risk Assessment
Jeff Swartout, U.S. EPA
Risks from Various Exposure Durations
Ron Brown, FDA
4 June 2001
Compound Specific Adjustment Factors – An International Perspective
Bette Meek, Health Canada
3 April 2001
A Model for the Development of Tolerable Upper Intake Levels for Nutrients
Elizabeth Reese; Joseph Rodricks, The Life Science Consultancy
Steve Taylor, University of Nebraska
3 October 2000
Microbial Dose-Response Modeling: Surrogate Dose-Response Models for the Foodborne Pathogen E. coli O157:H7
Peg Coleman, USDA
6 June 2000